Triptorelin的全球市場:規模，佔有率，趨勢，預測(2022年～2028年)

全球Triptorelin的市場規模，由於前列腺癌症和唾液腺癌症的發生率增加，及8～9歲以下的青年人的中樞性性早熟的盛行率上升，術後輔助性治療的使用可能性等所促進。

本報告提供全球Triptorelin市場調查，市場概要，市場規模和預測，趨勢，成長要素，阻礙因素，各藥物類型、用途、地區的分析，及競爭情形等資訊。

目錄

第1章 調查目的、前提條件

• 調查目的
• 假設
• 簡稱

第2章 市場概要

• 報告的說明
  • 市場定義和範圍
• 摘要整理
  • 市場明細:各藥物類型
  • 市場明細:各用途
  • 市場明細:各流通管道
  • 市場明細:各地區
• Coherent Opportunity Map(COM)

第3章 市場動態，法規，及趨勢分析

• 市場動態
  • 促進因素
  • 阻礙因素
  • 市場機會
• 法規情境
• 市場趨勢
• 流行病學
• 新產品的認證/銷售
• 合併/收購
• 策略性合作
• PEST分析

第4章 全球Triptorelin市場:各藥物類型(2017年～2028年)

• 簡介
• Triptorelin Pamoate
• 醋酸Triptorelin
• Triptorelin Embonate

第5章 全球Triptorelin市場:各用途(2017年～2028年)

• 簡介
• 前列腺癌症
• 前列腺全摘除術
• 子宮內膜異位症
• 唾液腺癌症
• 中樞性性早熟

第6章 全球Triptorelin市場:各流通管道(2017年～2028年)

• 簡介
• 醫院藥局
• 零售藥局
• 線上藥局

第7章 全球Triptorelin市場:各地區(2017年～2028年)

• 簡介
• 北美
• 美國
• 加拿大
• 歐洲
• 英國
• 德國
• 義大利
• 法國
• 西班牙
• 俄羅斯
• 其他歐洲
• 亞太地區
• 中國
• 日本
• 印度
• ASEAN
• 澳洲
• 韓國
• 其他亞太地區
• 南美
• 巴西
• 墨西哥
• 阿根廷
• 其他南美國家
• 非洲
• 北非
• 中非
• 南非
• 中東
• GCC各國
• 以色列
• 其他中東

第8章 競爭情形

• 熱圖分析
• 企業簡介
  • Ipsen
  • Bachem
  • Ferring Pharmaceuticals Pvt Ltd.
  • Chengdu Tiantaishan pharmaceutical Co., Ltd.
  • Tecnofarma
  • Dr. Reddy's Laboratories Ltd.
  • Teva Pharmaceutical Industries Ltd.(Actavis Specialty Pharmaceuticals Co.)
  • Debiopharm Group
  • Arbor Pharmaceuticals, LLC
• 分析師的見解

第9章 Section

Triptorelin is a peptide formulation for injection that was developed mainly for the treatment of advanced metastatic prostate cancer. Furthermore, other indications developed subsequently include the treatment of uterine fibroids (a benign tumor of muscle tissues in the uterus), endometriosis (proliferation of endometrial tissue, the mucous membrane that lines the uterine wall outside the reproductive tract) prior to surgery or when surgery is not deemed appropriate, as well as early onset puberty and female infertility (in vitro fertilization). Other modalities of triptorelin such as triptorelin acetate, triptorelin pamoate and triptorelin embonate are also used for prostate cancer treatment.

Market Dynamics

Triptorelin market is expected to witness lucrative growth opportunities during forecast period, owing to increasing incidence of prostate cancer and salivary gland cancer and increasing prevalence of central precocious puberty among the young patients below age eight and nine years, worldwide. For instance, according to National Organization for Rare Disorders (NORD), 2016 data findings, Central Precocious Puberty (CPP), accounted for 1 to 5 in 10,000 children with a female to male ratio of about 20:1, in U.S.

In March 2021, Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK, in coordination with fourteen other European regulatory agencies approved a new indication of Decapeptyl (triptorelin). According to these new indication, Decapeptyl (triptorelin) will be used as adjuvant treatment in combination with tamoxifen or aromatase inhibitor for endocrine-responsive early-stage breast cancer in women at high-risk of recurrence who are confirmed as pre-menopausal after completion of chemotherapy. This would enhance the revenue for growth for triptorelin market, during forecast period.

Furthermore, higher efficacy and tolerability of triptorelin in suppression of gonadotropin secretion in prostate cancer and precocious puberty is increasing adoption of triptorelin in the market.

Key features of the study:

This report provides in-depth analysis of triptorelin market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players

It profiles leading players in the global triptorelin market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans

Key companies covered as a part of this study include Ipsen, Bachem, Ferring Pharmaceuticals Pvt Ltd., Chengdu Tiantaishan pharmaceutical Co., Ltd., Tecnofarma, Dr. Reddy’s Laboratories Ltd., Teva Pharmaceutical Industries Ltd. (Actavis Specialty Pharmaceuticals Co.), Debiopharm Group, and Arbor Pharmaceuticals, LLC.

Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics

The global triptorelin market report caters to various stakeholders in this industry including investors, suppliers, triptorelin based product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the triptorelin market.

Detailed Segmentation:

Global Triptorelin Market, By Drug Type:

Triptorelin Pamoate

Triptorelin Acetate

Triptorelin Embonate

Global Triptorelin Market, By Application:

Prostate Cancer

Radical Prostatectomy

Endometriosis

Salivary Gland Cancer

Central Precocious Puberty

Global Triptorelin Market, By Distribution Channel:

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Global Triptorelin Market, By Geography:

North America

By Country:

U.S.

Canada

By Drug Type:

Decapeptyl SR

Trelstar

Decapeptyl SR

Gonapeptyl depot

Salvacyl

Triptorelin pamoate

Triptorelin acetate

Triptorelin embonate

By Application

Prostate Cancer

Radical Prostatectomy

Endometriosis

Salivary Gland Cancer

Central Precocious Puberty

By Distribution Channel:

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Europe

By Country:

Germany

France

Italy

UK

Spain

Russia

Rest of Europe

By Drug Type:

Triptorelin pamoate

Decapeptyl SR

Trelstar

Triptorelin acetate

Decapeptyl SR

Gonapeptyl depot

Triptorelin embonate

Salvacyl

By Application

Prostate Cancer

Radical Prostatectomy

Endometriosis

Salivary Gland Cancer

Central Precocious Puberty

By Distribution Channel:

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Asia Pacific

By Country:

China

India

Japan

South Korea

Australia

Rest of Asia Pacific

By Drug Type:

Triptorelin pamoate

Decapeptyl SR

Trelstar

Triptorelin acetate

Decapeptyl SR

Gonapeptyl depot

Triptorelin embonate

Salvacyl

By Application

Prostate Cancer

Radical Prostatectomy

Endometriosis

Salivary Gland Cancer

Central Precocious Puberty

By Distribution Channel:

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Middle East

By Country:

GCC

Israel

Rest of Middle East

By Drug Type:

Triptorelin pamoate

Decapeptyl SR

Trelstar

Triptorelin acetate

Decapeptyl SR

Gonapeptyl depot

Triptorelin embonate

Salvacyl

By Application

Prostate Cancer

Radical Prostatectomy

Endometriosis

Salivary Gland Cancer

Central Precocious Puberty

By Distribution Channel:

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Latin America

By Country:

Brazil

Argentina

Mexico

Rest of Latin America

By Drug Type:

Triptorelin pamoate

Decapeptyl SR

Trelstar

Triptorelin acetate

Decapeptyl SR

Gonapeptyl depot

Triptorelin embonate

Salvacyl

By Application

Prostate Cancer

Radical Prostatectomy

Endometriosis

Salivary Gland Cancer

Central Precocious Puberty

By Distribution Channel:

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Africa

By Country:

South Africa

Central Africa

North Africa

By Drug Type:

Triptorelin pamoate

Decapeptyl SR

Trelstar

Triptorelin acetate

Decapeptyl SR

Gonapeptyl depot

Triptorelin embonate

Salvacyl

By Application

Prostate Cancer

Radical Prostatectomy

Endometriosis

Salivary Gland Cancer

Central Precocious Puberty

By Distribution Channel:

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Company Profiles

Ipsen *

Company Overview

Product Portfolio

Financial Performance

Recent Developments

Strategies

Bachem

Ferring Pharmaceuticals Pvt Ltd.

Chengdu Tiantaishan pharmaceutical Co., Ltd.

Tecnofarma

Reddy’s Laboratories Ltd.

Teva Pharmaceutical Industries Ltd. (Actavis Specialty Pharmaceuticals Co.)

Debiopharm Group

Arbor Pharmaceuticals, LLC

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

• Research Objectives
• Assumptions
• Abbreviations

2. Market Overview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Drug Type
  • Market Snippet, By Application
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Regulatory Scenario
• Market Trends
• Epidemiology
• New Product Approvals/Launch
• Mergers/ Acquisition
• Strategic Collaborations
• PEST Analysis

4. Global Triptorelin Market, By Drug Type, 2017-2028 (US$ Million)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Triptorelin pamoate
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Triptorelin acetate
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Triptorelin embonate
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

5. Global Triptorelin Market, By Application, 2017-2028 (US$ Million)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Prostate Cancer
  • Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
• Radical Prostatectomy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Endometriosis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Salivary Gland Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Central Precocious Puberty
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

6. Global Triptorelin Market, By Distribution Channel, 2017-2028 (US$ Million)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Hospital Pharmacy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Retail Pharmacy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Online Pharmacy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

7. Global Triptorelin Market, By Regions, 2017-2028 (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017 - 2028
• North America
  • Market Size and Forecast, By Drug Type, 2017-2028 (US$ Million)
  • Market Size and Forecast, By Application, 2017-2028 (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2017-2028 (US$ Million)
  • Market Size and Forecast, By Country, 2017-2028, (US$ Million)
• U.S.
• Canada
• Europe
  • Market Size and Forecast, By Drug Type, 2017-2028 (US$ Million)
  • Market Size and Forecast, By Application, 2017-2028 (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2017-2028 (US$ Million)
  • Market Size and Forecast, By Country, 2017-2028, (US$ Million)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Market Size and Forecast, By Drug Type, 2017-2028 (US$ Million)
  • Market Size and Forecast, By Application, 2017-2028 (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2017-2028 (US$ Million)
  • Market Size and Forecast, By Country, 2017-2028, (US$ Million)
• China
• Japan
• India
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
  • Market Size and Forecast, By Drug Type, 2017-2028 (US$ Million)
  • Market Size and Forecast, By Application, 2017-2028 (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2017-2028 (US$ Million)
  • Market Size and Forecast, By Country, 2017-2028, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Africa
  • Market Size and Forecast, By Drug Type, 2017-2028 (US$ Million)
  • Market Size and Forecast, By Application, 2017-2028 (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2017-2028 (US$ Million)
  • Market Size and Forecast, By Country, 2017-2028, (US$ Million)
• North Africa
• Central Africa
• South Africa
• Middle East
  • Market Size and Forecast, By Drug Type, 2017-2028 (US$ Million)
  • Market Size and Forecast, By Application, 2017-2028 (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2017-2028 (US$ Million)
  • Market Size and Forecast, By Country, 2017-2028, (US$ Million)
• GCC Countries
• Israel
• Rest of Middle East

8. Competitive Landscape

• Heat Map Analysis
• Company Profiles
  • Ipsen
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • Bachem
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • Ferring Pharmaceuticals Pvt Ltd.
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • Chengdu Tiantaishan pharmaceutical Co., Ltd.
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • Tecnofarma
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • Dr. Reddy's Laboratories Ltd.
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • Teva Pharmaceutical Industries Ltd. (Actavis Specialty Pharmaceuticals Co.)
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • Debiopharm Group
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • Arbor Pharmaceuticals, LLC
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
• Analyst Views

9. Section

• References
• Analyst Views
• Research Methodology
• About Us and Sales Contact